Last update:
Medications news
Medications
Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds
A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia ...
5 hours ago
0
32
Medications
Anti-platelet drug can slow metastasis in aggressive cancers, research shows
Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches ...
4 hours ago
0
0
FDA approves Itvisma for spinal muscular atrophy
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...
2 hours ago
0
0
Men and women may need different medications to avoid broken bones
A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent fractures, and death in people ...
7 hours ago
0
0
Opioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections.
4 hours ago
0
0
Telling people to use antibiotics responsibly isn't enough. What will work instead?
Antimicrobial resistance is projected to cause up to 10 million deaths each year by 2050, making it one of the most pressing global health challenges of this century. In 2021, an estimated 4.71 million deaths were associated ...
4 hours ago
0
0
Medical cannabis linked to reduced opioid use in adults with chronic pain
Adults with chronic pain who participated in New York State's (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study published in JAMA Internal Medicine and ...
5 hours ago
0
0
Potentially life-threatening medicine interactions combated with new database
A comprehensive webpage-based database, named as IMgateway, currently offers rigorous, evidence-based information on the integration of complementary and conventional medicine but has lacked data on Chinese herbal medicines—until ...
5 hours ago
0
0
Emergency departments fall short on delivering timely treatment for sickle cell pain, study finds
A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle cell disease received appropriate opioid-based pain-relieving medications within the first hour ...
Dec 6, 2025
0
0
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of pregnancies involving hydroxyurea exposure. The ...
Dec 6, 2025
0
0
Study finds cystic fibrosis drug allows patients to safely scale back lung therapies
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments ...
Dec 5, 2025
0
68
Innovative drug delivery mechanism triggered by cooling could provide targeted pain relief
Leon Bellan, associate professor of mechanical and biomedical engineering at Vanderbilt, and his team have developed a novel cooling-triggered device that could allow patients to safely and conveniently receive drugs for ...
Dec 5, 2025
0
0
GLP-1RAs shown to reduce risk of cardiovascular death
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials ...
Dec 5, 2025
0
0
New UK guideline for clopidogrel recommends pharmacogenetic testing for all patients before prescription
The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use of the antiplatelet medication ...
Dec 4, 2025
0
1
Experimental drug repairs DNA damage caused by common diseases
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.
Dec 3, 2025
0
23
Pegcetacoplan—the 'closest thing to a cure' for rare, severe kidney disease
A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering research and clinical leadership from University of Iowa Health Care Stead Family Children's Hospital.
Dec 3, 2025
0
34
Consumers pay when drugmakers delay, finds study of over-the-counter drug exclusivity rules
Policies designed to encourage drugmakers to introduce over-the-counter (OTC) versions of previously prescription-only medications may in fact harm consumers, shows a new study co-authored by a University of Massachusetts ...
Dec 3, 2025
0
0
Long-term antidepressant use surges in Australia, sparking warnings of overprescribing
Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10–24, where rates have more than doubled.
Dec 3, 2025
0
0
Recent changes to EU chemicals legislation are rarely reflected in the EU pharmaceutical sector
Several changes have been made to EU chemicals policy and legislation with the aim of making society greener. These changes may affect the pharmaceutical sector in many ways, but they are rarely reflected in pharmaceutical ...
Dec 3, 2025
0
0
Pain med side effects may be masquerading as heart failure
Clinicians may fail to recognize common side effects of drugs like gabapentin—which are frequently prescribed for nerve pain—leading them to prescribe unnecessary medications that cause yet more side effects. This phenomenon, ...
Dec 2, 2025
0
59
Omomyc enhances PARP inhibitor effects and overcomes resistance in breast cancer models
Findings from a preclinical study demonstrate that Omomyc—the only direct MYC inhibitor to have successfully completed a phase I clinical trial—causes DNA damage in cancer cells which is synergistically enhanced in combination ...
Dec 2, 2025
0
0
How anti-epilepsy drugs alter a key brain protein structure
A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect their target.
Dec 2, 2025
0
0
WHO issues first guidance on using GLP-1 drugs to treat obesity
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Dec 2, 2025
0
0
Common water pill may help HIV medicines work faster and reduce inflammation, early study suggests
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, according to new research from the Valente lab at The Herbert ...
Dec 2, 2025
0
0
During blood pressure treatment, doctors recommend the use of sun protection
Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden shows a possible increased risk of basal cell carcinoma with certain blood pressure medications. The ...
Dec 2, 2025
0
0
